Skip to content

Pda Technical Report 82 _best_ Official

Based on PDA TR 82, here is how a Quality Control laboratory should implement a program today.

The report provides guidance on the measurement of extractables and leachables, including: pda technical report 82

LER occurs when spiked endotoxin standards cannot be recovered from a drug product matrix using traditional Factor C-based assays, such as the Limulus Amebocyte Lysate (LAL) test or recombinant Factor C (rFC). Based on PDA TR 82, here is how

: Explains how specific combinations, such as chelators (citrate/phosphate) and surfactants (polysorbate), cause endotoxin masking. Based on PDA TR 82

developed TR 82 to harmonize industry practices and provide a scientifically sound framework for managing LER. The report serves several critical functions: Parenteral Drug Association Technical Report No. 82: Low Endotoxin Recovery | PDA